Ajanta Pharma Statistics
Total Valuation
Ajanta Pharma has a market cap or net worth of INR 419.97 billion. The enterprise value is 415.74 billion.
Market Cap | 419.97B |
Enterprise Value | 415.74B |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
Earnings Date | Oct 31, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Ajanta Pharma has 125.35 million shares outstanding. The number of shares has decreased by -1.24% in one year.
Shares Outstanding | 125.35M |
Shares Change (YoY) | -1.24% |
Shares Change (QoQ) | -0.12% |
Owned by Insiders (%) | 53.42% |
Owned by Institutions (%) | 23.57% |
Float | 42.31M |
Valuation Ratios
The trailing PE ratio is 49.44 and the forward PE ratio is 41.98. Ajanta Pharma's PEG ratio is 3.23.
PE Ratio | 49.44 |
Forward PE | 41.98 |
PS Ratio | 9.73 |
PB Ratio | 11.90 |
P/FCF Ratio | n/a |
PEG Ratio | 3.23 |
Enterprise Valuation
EV / Earnings | 48.69 |
EV / Sales | 9.60 |
EV / EBITDA | 33.66 |
EV / EBIT | 37.66 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 1.03 |
Debt / EBITDA | 0.03 |
Debt / FCF | n/a |
Interest Coverage | 155.70 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 19.62% |
Revenue Per Employee | 5.37M |
Profits Per Employee | 1.06M |
Employee Count | 8,073 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +92.59% in the last 52 weeks. The beta is 0.11, so Ajanta Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.11 |
52-Week Price Change | +92.59% |
50-Day Moving Average | 2,697.18 |
200-Day Moving Average | 2,307.20 |
Relative Strength Index (RSI) | 71.95 |
Average Volume (20 Days) | 239,419 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ajanta Pharma had revenue of INR 43.33 billion and earned 8.54 billion in profits. Earnings per share was 67.77.
Revenue | 43.33B |
Gross Profit | 31.96B |
Operating Income | 11.04B |
Pretax Income | 11.67B |
Net Income | 8.54B |
EBITDA | 12.23B |
EBIT | 11.04B |
Earnings Per Share (EPS) | 67.77 |
Balance Sheet
The company has 4.60 billion in cash and 368.40 million in debt, giving a net cash position of 4.23 billion or 33.72 per share.
Cash & Cash Equivalents | 4.60B |
Total Debt | 368.40M |
Net Cash | 4.23B |
Net Cash Per Share | 33.72 |
Equity (Book Value) | 35.67B |
Book Value Per Share | 281.60 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 73.76%, with operating and profit margins of 25.48% and 19.71%.
Gross Margin | 73.76% |
Operating Margin | 25.48% |
Pretax Margin | 26.94% |
Profit Margin | 19.71% |
EBITDA Margin | 28.22% |
EBIT Margin | 25.48% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 36.00, which amounts to a dividend yield of 1.07%.
Dividend Per Share | 36.00 |
Dividend Yield | 1.07% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | n/a |
Buyback Yield | 1.24% |
Shareholder Yield | 2.31% |
Earnings Yield | 2.02% |
FCF Yield | n/a |
Stock Splits
The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.
Last Split Date | Jun 22, 2022 |
Split Type | Forward |
Split Ratio | 1.5 |